We have the ONTT (Optic Neuritis Treatment Trial) info to look at which tells us that the "probability of developing MS by 15 years after onset of optic neuritis was 50% and was strongly related to the presence of lesions on a baseline non-contrast-enhanced MRI of the brain. Twenty-five percent of patients with no lesions on baseline brain MRI developed MS during follow-up, compared with 72% of patients with 1 or more lesions."
I want all to know I am just starting Low Dose Naltrexone (LDN). Stopped the Enbrel, Plaquenil, Celebrex, muscle relaxers, Methotrexate and other meds, and am only taking my blood pressure meds, hormone therapy and this LDN! I am STRONGER, less fatigued, and am doing very well in many areas!! I just wanted all of you to realize this LDN is out there, it's available and works well for most of us.
Copyright 1994-2018MedHelp.All rights reserved. MedHelp is a division of Vitals Consumer Services, LLC.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.